Ojomona Oboro Abuh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ojomona Oboro Abuh has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Akinlabi M. Rufia
Department of Animal and Environmental Biology (Formerly Zoology Department), Osun State University, Osogbo, Nigeria
2 shared publicationsKamilu A. Fasasi
Department of Animal and Environmental Biology (Formerly Zoology Department), Osun State University, Osogbo, Nigeria
2 shared publicationsLuqmon A. Azeez
Department of Pure and Applied Chemistry, Osun State University, Osogbo, Nigeria
2 shared publicationsMonsuru A. Adeleke
Department of Animal and Environmental Biology (Formerly Zoology Department), Osun State University, Osogbo, Nigeria
2 shared publications- Babafemi Siji Ajisebiola
Osun State University
1 shared publication - Folasade Muibat Adeyemi
Department of Microbiology, Osun State University, Osogbo, Nigeria
1 shared publication
Latest Publications
- 12 July 2026
- Published by Taylor & Francis in Journal of Applied Aquaculture
- Vol. 38 (4) , 460-481
Physiological and microbiota profiling of African catfish ( Clarias gariepinus ) challenged with Bdellovibrio sp.: implications for safe pathogen control in fish production
Aquaculture, including fish farming, is recognized by Food and Agriculture Organization (FAO) as one of the fastest-growing agricultural practices and food sectors worldwide (FAO 2020a, 2020b; Taco...
- 12 July 2026
- Published by Taylor & Francis in Journal of Applied Aquaculture
- Vol. 38 (4) , 460-481
Physiological and microbiota profiling of African catfish ( Clarias gariepinus ) challenged with Bdellovibrio sp.: implications for safe pathogen control in fish production
Aquaculture, including fish farming, is recognized by Food and Agriculture Organization (FAO) as one of the fastest-growing agricultural practices and food sectors worldwide (FAO 2020a, 2020b; Taco...
- 23 October 2025
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 49 (4) , 951-964
Green-synthesized silver and iron nanoparticles from Alstonia boonei and Terminalia catappa as antimalarial agents in mice models
Malaria remains a significant health burden, particularly in sub-Saharan Africa, exacerbated by growing parasite drug resistance. Nanoparticles offer a promising strategy for effective antimalarial drug delivery, mitigating resistance, and reducing toxicity. This study investigated the antiplasmodial efficacy of silver nanoparticles (AgNPs) and iron nanoparticles (FeNPs) green-synthesized using Alstonia boonei and Terminalia catappa extracts against Plasmodium berghei in mice. Characterization confirmed nanoparticle formation: visual color changes, UV–Vis SPR peaks (295 nm for T. catappa AgNPs, (TCA) 435 nm for A. boonei AgNPs (AA), 270 nm for T. catappa FeNPs (TCF), 242 nm for A. boonei FeNPs (AF), FTIR identification of capping functional groups, and SEM–EDX elemental confirmation (Ag: 77.20% and 65.20%; Fe: 60.24% and 71.40%). Acute toxicity (LD50) tests showed high safety, with TCA, AA, and TCF exhibiting above 5000 mg/kg, while AF’s LD50 was 223.6 mg/kg. In curative assays, all nanoparticles demonstrated dose-dependent P. berghei inhibition, with AA 100 mg/kg achieving the highest at 75.6%. Prophylactic tests revealed impressive efficacy, with TCF 100 mg/kg showing 94.1% inhibition, and other nanoparticles above 87.0%. No significant difference (P > 0.05) in efficacy was observed among different nanoparticle dosages. These findings underscore the dose-dependent curative and prophylactic antiplasmodial activities of these green-synthesized nanoparticles, advocating for their further development as accessible antimalarial options.
- 23 October 2025
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 49 (4) , 951-964
Green-synthesized silver and iron nanoparticles from Alstonia boonei and Terminalia catappa as antimalarial agents in mice models
Malaria remains a significant health burden, particularly in sub-Saharan Africa, exacerbated by growing parasite drug resistance. Nanoparticles offer a promising strategy for effective antimalarial drug delivery, mitigating resistance, and reducing toxicity. This study investigated the antiplasmodial efficacy of silver nanoparticles (AgNPs) and iron nanoparticles (FeNPs) green-synthesized using Alstonia boonei and Terminalia catappa extracts against Plasmodium berghei in mice. Characterization confirmed nanoparticle formation: visual color changes, UV–Vis SPR peaks (295 nm for T. catappa AgNPs, (TCA) 435 nm for A. boonei AgNPs (AA), 270 nm for T. catappa FeNPs (TCF), 242 nm for A. boonei FeNPs (AF), FTIR identification of capping functional groups, and SEM–EDX elemental confirmation (Ag: 77.20% and 65.20%; Fe: 60.24% and 71.40%). Acute toxicity (LD50) tests showed high safety, with TCA, AA, and TCF exhibiting above 5000 mg/kg, while AF’s LD50 was 223.6 mg/kg. In curative assays, all nanoparticles demonstrated dose-dependent P. berghei inhibition, with AA 100 mg/kg achieving the highest at 75.6%. Prophylactic tests revealed impressive efficacy, with TCF 100 mg/kg showing 94.1% inhibition, and other nanoparticles above 87.0%. No significant difference (P > 0.05) in efficacy was observed among different nanoparticle dosages. These findings underscore the dose-dependent curative and prophylactic antiplasmodial activities of these green-synthesized nanoparticles, advocating for their further development as accessible antimalarial options.
- Open Access
- 17 August 2025
- Published by Stecab Publishing in Journal of Environment, Climate, and Ecology
- Vol. 2 (2) , 38-43
Larvicidal Efficacy of Green-Synthesized Silver Nanoparticles from Alstonia boonei and Terminalia catappa against Anopheles gambiae
This study investigates the eco-friendly synthesis of silver nanoparticles (AgNPs) using aqueous extracts of Alstonia boonei (AA) and Terminalia catappa (TCA) and evaluates their larvicidal efficacy against the fourth-instar larvae of Anopheles gambiae. The bio-reduction of silver ions (Ag+) to elemental silver (Ag0) was confirmed by a color change and the Surface Plasmon Resonance (SPR) peak at 435 nm, indicating successful AgNP formation. FTIR analysis identified functional groups, such as O-H, C-H, and N groups, which acted as both reducing and capping agents. Scanning electron microscopy with energy-dispersive X-ray spectroscopy (SEM-EDXs) confirmed the presence of silver (77.20 %) in the biosynthesized nanoparticles. The larvicidal activity was evaluated following WHO (2005) protocol, different concentrations of the nanoparticles: 50, 100, 150, 200 and 250 mgL-1 was used, 25 fourth-instar larvae of was exposed to each concentration, with three replicate for each test. Both AA and TCA-synthesized AgNPs exhibited concentration-dependent larvicidal activity. AA proved to be the most potent, with a lethal concentration (LC50) of 65.2 % Cl after just one hour of exposure. Upon the initial treatment, the TCA was not very effective as compared to AA. After 12 hours, it became much more potent, with an LC50 of 34.5 %. The tiny size of the nanoparticles helped them get through the larval membrane easily. Once inside, they invade the cells, which caused the larvae to die. This shows that the silver nanoparticles, made from these plant extracts, could be a great, eco-friendly way to control mosquitoes.
- 17 August 2025
- Published by Stecab Publishing in Journal of Environment, Climate, and Ecology
- Vol. 2 (2) , 38-43
Open AccessLarvicidal Efficacy of Green-Synthesized Silver Nanoparticles from Alstonia boonei and Terminalia catappa against Anopheles gambiae
This study investigates the eco-friendly synthesis of silver nanoparticles (AgNPs) using aqueous extracts of Alstonia boonei (AA) and Terminalia catappa (TCA) and evaluates their larvicidal efficacy against the fourth-instar larvae of Anopheles gambiae. The bio-reduction of silver ions (Ag+) to elemental silver (Ag0) was confirmed by a color change and the Surface Plasmon Resonance (SPR) peak at 435 nm, indicating successful AgNP formation. FTIR analysis identified functional groups, such as O-H, C-H, and N groups, which acted as both reducing and capping agents. Scanning electron microscopy with energy-dispersive X-ray spectroscopy (SEM-EDXs) confirmed the presence of silver (77.20 %) in the biosynthesized nanoparticles. The larvicidal activity was evaluated following WHO (2005) protocol, different concentrations of the nanoparticles: 50, 100, 150, 200 and 250 mgL-1 was used, 25 fourth-instar larvae of was exposed to each concentration, with three replicate for each test. Both AA and TCA-synthesized AgNPs exhibited concentration-dependent larvicidal activity. AA proved to be the most potent, with a lethal concentration (LC50) of 65.2 % Cl after just one hour of exposure. Upon the initial treatment, the TCA was not very effective as compared to AA. After 12 hours, it became much more potent, with an LC50 of 34.5 %. The tiny size of the nanoparticles helped them get through the larval membrane easily. Once inside, they invade the cells, which caused the larvae to die. This shows that the silver nanoparticles, made from these plant extracts, could be a great, eco-friendly way to control mosquitoes.
- Open Access
Green-synthesized silver and iron nanoparticles from Alstonia boonei and Terminalia catappa as antimalarial agents in mice models
Malaria a major health scourge of high impact in sub-sahara, with a major control-drawback on issues of resistance of the parasite to antimalaria. Nanoparticles have been investigated for their capacity to effectively deliver antimalarial drugs to kill the parasites, avoid drug resistance evolution and maintain a low toxic side effects. This study investigated the antiplasmodial efficacies of two plant green-synthesized with AgNO 3 and FeSO 4 salts against Plasmodium berghei infected mice using, an acute toxicity test (LD 50 ) of the Terminalia-catappa AgNPs (TCA), Alstonia-boonei AgNPs (AA), Terminalia-catappa FeSO 4 (TCF) and Alstonia-boonei FeSO 4 (AF) in accordance with Lorke’s method. The LD 50 was above 5000 mg/kg of TCA and AA while 223.6 mg/kg in TCF and AF. Each nanoparticles exhibited high dose dependent P. berghei inhibition which was 62.20 % and 75.6 % in the TCA 200 mg/kg AA 100 mg/kg, 61.5 % and 75.3 % in the TCF 300 mg/kg and AF 200 mg/kg and doses in the curative groups, 92. 4 % and 93.1 % for TCA 100 mg/kg, AA 100 mg/kg 94.1 in 100 mg/kg dose and AF had 92.1 % at 300 mg/kg doses in the prophylactic groups. The groups treated with orthodox drugs had low parasitemia while the negative control recorded high parasitemia. There was no significant difference (P ˃ 0.05) in the mean change of the dosage in the different nanoparticles. These findings revealed all nanoparticles possesses a dose-dependent curative and prophylactic antiplasmodial activity and calls for their development and standardization as effective and readily available antimalarial options.
Open AccessGreen-synthesized silver and iron nanoparticles from Alstonia boonei and Terminalia catappa as antimalarial agents in mice models
Malaria a major health scourge of high impact in sub-sahara, with a major control-drawback on issues of resistance of the parasite to antimalaria. Nanoparticles have been investigated for their capacity to effectively deliver antimalarial drugs to kill the parasites, avoid drug resistance evolution and maintain a low toxic side effects. This study investigated the antiplasmodial efficacies of two plant green-synthesized with AgNO 3 and FeSO 4 salts against Plasmodium berghei infected mice using, an acute toxicity test (LD 50 ) of the Terminalia-catappa AgNPs (TCA), Alstonia-boonei AgNPs (AA), Terminalia-catappa FeSO 4 (TCF) and Alstonia-boonei FeSO 4 (AF) in accordance with Lorke’s method. The LD 50 was above 5000 mg/kg of TCA and AA while 223.6 mg/kg in TCF and AF. Each nanoparticles exhibited high dose dependent P. berghei inhibition which was 62.20 % and 75.6 % in the TCA 200 mg/kg AA 100 mg/kg, 61.5 % and 75.3 % in the TCF 300 mg/kg and AF 200 mg/kg and doses in the curative groups, 92. 4 % and 93.1 % for TCA 100 mg/kg, AA 100 mg/kg 94.1 in 100 mg/kg dose and AF had 92.1 % at 300 mg/kg doses in the prophylactic groups. The groups treated with orthodox drugs had low parasitemia while the negative control recorded high parasitemia. There was no significant difference (P ˃ 0.05) in the mean change of the dosage in the different nanoparticles. These findings revealed all nanoparticles possesses a dose-dependent curative and prophylactic antiplasmodial activity and calls for their development and standardization as effective and readily available antimalarial options.